AI assistant
Sending…
Edesa Biotech, Inc. — Director's Dealing 2020
Feb 15, 2020
35006_dirs_2020-02-14_eb400e17-7d84-4395-83d1-d50091ffd9eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edesa Biotech, Inc. (EDSA)
CIK: 0001540159
Period of Report: 2020-02-12
Reporting Person: NIFFENEGGER KATHI (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-12 | Share Option (Right to Buy) | $3.16 | A | 88699 | Acquired | 2030-02-12 | Common Shares (88699) | Direct |
Footnotes
F1: 33% vested on 2/12/2020, with a prorata amount of the balance vesting monthly thereafter over the next 36 months until fully vested
More from Edesa Biotech, Inc.
Regulatory Filings
2026
May 29
Declaration of Voting Results & Voting Rights Announcements
2026
May 29
Board/Management Information
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Annual Report
2026
Apr 3
Proxy Solicitation & Information Statement
2026
Apr 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2